Acinetobacter Baumannii
Conditions
Keywords
Acinetobacter baumannii, Imipenem-resistant
Brief summary
Colonization with imipenem-resistant Acinetobacter baumannii (IBA) is an unfavorable event for the patient, especially in intensive care. Indeed, it exposes the patient to the risk of developing serious infections, extremely difficult to treat. ABRI is a particularly resistant bacterium in the environment. When an ABRI epidemic occurs in a department as central to the hospital as a surgical resuscitation department, the control of such an event can be extremely complex. There are few clear and detailed descriptions in the literature of how to manage this type of outbreak, let alone an ABRI outbreak of this magnitude.
Interventions
None listed
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Major subject (≥18 years old) * Patient having been hospitalized in the surgical resuscitation service of Hautepierre during the ABRI epidemic, between 01/05/2015 and 01/01/2019 inclusive and having been colonized and/or infected by ABRI (according to bacteriological results transmitted to the hygiene service). * Subject having given his/her agreement, after information, for the reuse of his/her data for the purpose of this research
Exclusion criteria
* Subject having expressed his opposition to participate in the study * Subject under guardianship or curatorship * Subject under legal protection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Retrospective description of the management of an imipenem-resistant Acinetobacter baumannii outbreak that occurred from 2015 to 2019 in a surgical intensive care unit | Through study completion, an average of 5 months |
Countries
France
Contacts
Primary ContactStéphanie DEBOSCKER, MD
Outcome results
None listed